New tools for achieving tuberculosis control: progress and reflexion.

[1]  Eduardo Gotuzzo,et al.  Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.

[2]  A. Nunn,et al.  Global tuberculosis drug development pipeline: the need and the reality , 2010, The Lancet.

[3]  S. Kaufmann,et al.  New vaccines for tuberculosis , 2010, The Lancet.

[4]  Alimuddin Zumla,et al.  Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice , 2010, The Lancet.

[5]  Alimuddin Zumla,et al.  Trials and tribulations of an African‐led research and capacity development programme: the case for EDCTP investments , 2010, Tropical medicine & international health : TM & IH.

[6]  M. Raviglione,et al.  New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes , 2010, Current opinion in pulmonary medicine.

[7]  Irene Ayakaka,et al.  Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology , 2009, Journal of Clinical Microbiology.

[8]  Alimuddin Zumla,et al.  Biomarkers for tuberculosis disease status and diagnosis , 2009, Current opinion in pulmonary medicine.

[9]  S. Kaufmann,et al.  Tuberculosis in Africa: learning from pathogenesis for biomarker identification. , 2008, Cell host & microbe.

[10]  Dirk Repsilber,et al.  Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis , 2007, Journal of Molecular Medicine.

[11]  P. Farmer,et al.  Historical declines in tuberculosis: nature, nurture and the biosocial model. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  D Repsilber,et al.  Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.